April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Investigating the Ability of Anti-Oxidant Gene Expression in Mesenchymal Stem Cells to Promote Cell Protection and Recovery in an in vitro Model of Age-Related Macular Degeneration
Author Affiliations & Notes
  • A. P. Lynch
    Regenerative Medicine Institute, Galway, Ireland
  • L. McGinley
    Regenerative Medicine Institute, Galway, Ireland
  • C. Sheridan
    School of Clinical Sciences, Opthalmology Research Unit, Liverpool, United Kingdom
  • C. Coleman
    Regenerative Medicine Institute, Galway, Ireland
  • L. Howard
    Regenerative Medicine Institute, Galway, Ireland
  • D. Kent
    Regenerative Medicine Institute, Galway, Ireland
  • F. Barry
    Regenerative Medicine Institute, Galway, Ireland
  • Footnotes
    Commercial Relationships  A.P. Lynch, None; L. McGinley, None; C. Sheridan, None; C. Coleman, None; L. Howard, None; D. Kent, None; F. Barry, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1443. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. P. Lynch, L. McGinley, C. Sheridan, C. Coleman, L. Howard, D. Kent, F. Barry; Investigating the Ability of Anti-Oxidant Gene Expression in Mesenchymal Stem Cells to Promote Cell Protection and Recovery in an in vitro Model of Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1443.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The aim of this study was to determine if lentiviral transduced mesenchymal stem cells (MSCs) expressing anti-oxidant genes could protect and recover the retinal pigment epithelial cell line, ARPE-19 from oxidative stress with tert-butylhydroperoxide (tert-BHP) treatment.

Methods: : ARPE-19 cells were treated with varying concentrations of tert-BHP, ranging from 1 - 8 mM, to induce features of age-related macular degeneration (AMD). Control cells remained untreated. MSCs were transduced with lentiviral vectors expressing GFP, Catalase, HSP-27, HSP-70, SOD-1 or SOD-3. GFP transduced MSCs were used as a control. Treated ARPE-19 cells were grown in co-culture with transduced MSCs. Cell viability was assessed with the MTT and Live / Dead assays, while the production of ROS was measured with carboxy-H2DCFDA.

Results: : Treatment with tert-BHP decreased the viability of ARPE-19 cells. Morphological changes and cell survival assays revealed that incubation with transduced MSCs aided ARPE-19 cells to resist the free radicals induced by tert-BHP. In addition, activity of SOD-1 and -3 was enhanced in ARPE-19 cells leading to a reduction in ROS levels.

Conclusions: : These results suggest that transduced MSCs have potent antioxidant activity and protect RPE from oxidative injury. Therefore transduced MSCs are possible candidates for the modulation of oxidative stress- induced damage of RPE in the ageing retina.

Keywords: age-related macular degeneration • oxidation/oxidative or free radical damage • retinal pigment epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×